Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/20/2025

Hypertension Management with Amlodipine and Hydrochlorothiazide

Current Medication Assessment

  • The patient is currently on two first-line antihypertensive medications: amlodipine (calcium channel blocker) and hydrochlorothiazide (thiazide diuretic), which is an appropriate but insufficient combination for blood pressure control in this case 1, 2
  • Adding an ACE inhibitor or ARB provides a complementary mechanism of action to the existing regimen, and this three-drug combination (CCB + thiazide diuretic + ACEI/ARB) is the preferred approach for patients requiring triple therapy 1, 2, 3
  • For non-Black patients, an ACE inhibitor would be preferred (e.g., perindopril 2-4 mg daily) 1, 4
  • For Black patients, an ARB may be more effective (e.g., losartan 50 mg daily) 1, 2

Medication Optimization

  • Consider replacing hydrochlorothiazide with a longer-acting thiazide-like diuretic such as chlorthalidone or indapamide for improved efficacy 5

Monitoring and Target Blood Pressure

  • Reassess blood pressure within 2-4 weeks after medication adjustment, with a target blood pressure of <140/90 mmHg for most patients 1, 5, 2

Additional Agents for Uncontrolled Hypertension

  • If blood pressure remains uncontrolled despite triple therapy, add spironolactone (aldosterone antagonist) as the preferred fourth-line agent, starting at 25 mg daily 1, 3
  • Alternative fourth-line options include amiloride, doxazosin, eplerenone, clonidine, or a beta-blocker 1, 3

Specialist Referral and Special Considerations

  • If blood pressure remains uncontrolled on ≥3 antihypertensive drugs or if multiple drug intolerances occur, consider referral to a specialist in hypertension 4
  • Monitor for side effects when adding an ACE inhibitor/ARB, including hyperkalemia, acute kidney injury, and cough (with ACE inhibitors) 2, 3
  • Avoid combining ACE inhibitors with ARBs due to increased risk of adverse effects without additional benefit 2
  • Home blood pressure monitoring is recommended to assess treatment effectiveness 1, 5
  • Ensure patient adherence to medications before adding new agents, and consider potential drug interactions when adding multiple antihypertensive medications 1, 2
  • Evaluate for secondary causes of hypertension if blood pressure remains difficult to control despite multiple medications 5
  • For elderly patients, be cautious about aggressive blood pressure lowering and monitor for orthostatic hypotension 1, 5